Pharmacovigilance—or monitoring the effects of medical drugs—is a critical phase in clinical trials. Fail to identify correlating side effects, and life sciences companies risk their consumers’ health, their reputation, and potentially billions of dollars. In this solution brief, we take a closer look at how major life sciences companies are adopting new practices around big data to heighten pharmacovigilance.
